Sylvain Garciaz - Concepedia

Author

Sylvain Garciaz

Also Known As

Camille Rouzaud, Garciaz, Sylvain, Marie‐Joelle Mozziconacci, Norbert Vey, S Garciaz, S. Garciaz, Sylvain Garciaz, V. Maisano, Valerio Maisano

190

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Institut Paoli-Calmettes Inserm Aix-Marseille Université Centre National de la Recherche Scientifique The University of Texas MD Anderson Cancer Center

About

Sylvain Garciaz is an author at Institut Paoli-Calmettes specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	166
2	Health Sciences	3	3	53
3	Cell Biology	2	2	75
4	Natural Sciences	1	1	31
5	Blood Transplantation	1	1	15

Sylvain Garciaz

Publications

788

Citations

H-Index

Page 1

	Year	Citations
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers Cédric Rossi, Julia Gilhodes, Marie Maerevoet, American Journal of Hematology	2018	116
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas Adèle de Masson, M. Beylot‐Barry, Jean‐David Bouaziz, Haematologica	2013	81
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients Sylvain Garciaz Cancers	2022	56
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma Sylvain Garciaz, Diane Coso, Frédéric Peyrade, Hematological Oncology	2013	47
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses Kah Lok Chan, Juliana Gomez, Chelisa Cardinez, Cancer Cell Cancer ImmunosurveillanceImmunologyTumor ImmunityImmunologic MechanismAnti-cancer Immune Responses	2022	44
Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers Sylvain Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, American Journal of Hematology	2018	42
A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring <i>KMT2A</i> or <i>NPM1</i> Alterations Elias Jabbour, Emma Searle, Maher Abdul‐Hay, Blood	2023	42
Patients’ Non-Medical Characteristics Contribute to Collective Medical Decision-Making at Multidisciplinary Oncological Team Meetings Léa Restivo, Thémis Apostolidis, Anne‐Déborah Bouhnik, PLoS ONE	2016	34
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity Myriam Koubi, Mathilde Poplineau, Julien Vernerey, Nucleic Acids Research Histone ModificationsPlzf Target GenesMolecular RegulationGeneticsEpigenetic Change	2018	31
Venetoclax Resistance in Acute Myeloid Leukemia Sylvain Garciaz Cancers	2024	29

Page 1